Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions

Current pharmacotherapy of Parkinson’s disease (PD) is symptomatic and palliative, with levodopa/carbidopa therapy remaining the prime treatment, and nevertheless, being unable to modulate the progression of the neurodegeneration. No available treatment for PD can enhance the patient’s life-quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Behl, Tapan, Kaur, Gagandeep, Bungau, Simona, Jhanji, Rishabh, Kumar, Arun, Mehta, Vineet, Zengin, Gokhan, Brata, Roxana, Hassan, Syed Shams ul, Fratila, Ovidiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504186/
https://www.ncbi.nlm.nih.gov/pubmed/32872273
http://dx.doi.org/10.3390/ijms21176235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504186/
https://www.ncbi.nlm.nih.gov/pubmed/32872273
http://dx.doi.org/10.3390/ijms21176235

Ejemplares similares